Small Molecules, Devices, Generics
Total Trials
10
As Lead Sponsor
As Collaborator
0
Total Enrollment
968
NCT00514657
Trial in Periodontal Tissue Regeneration Using Fibroblast Growth Factor-2
Phase: Phase 2
Role: Lead Sponsor
Start: Dec 31, 2001
Completion: Feb 29, 2004
NCT00199290
A Phase2 Clinical Trial of Trafermin in Patients With Marginal Periodontitis in Japan
Start: Aug 31, 2005
Completion: Dec 31, 2007
NCT00734708
Phase 3 Clinical Trial of Periodontal Tissue Regeneration Using Fibroblast Growth Factor-2(Trafermin)
Phase: Phase 3
Start: Aug 31, 2008
Completion: Not specified
NCT00932074
A Study to Determine the Safety, Tolerability and Efficacy of KP-413 in Subjects With Atopic Dermatitis(AD)
Phase: Phase 1/2
Start: Jul 31, 2009
Completion: Jun 30, 2010
NCT01015404
A Study to Assess the Safety of Using Fibroblast Growth Factor-2 With Periodontal Surgery in Japan (Phase 3)
Start: Nov 30, 2009
NCT06533878
Evaluate Tolerability and Safety of HY209 in Healthy Volunteers
Phase: Phase 1
Start: Sep 13, 2023
Completion: Dec 31, 2025
NCT06227832
A Study to Determine the Effect of KP-001 on Metformin and Midazolam Pharmacokinetics and the Effect of Clarithromycin on KP-001 Pharmacokinetics in Healthy Adult Participants
Start: Dec 15, 2023
Completion: Jul 31, 2024
NCT06649942
A Study to Evaluate the Effects of KP-001 on the QT/QTc Intervals in Healthy Adults
Start: Oct 1, 2024
Completion: Mar 24, 2025
NCT06619054
A Study to Evaluate the Effect of Hepatic Impairment on the Pharmacokinetics of KP-001
Start: Oct 24, 2024
Completion: Jul 4, 2025
NCT06821698
To Determine the Effect of KP-001 on Rosuvastatin, Caffeine PK and the Effect of Fluvoxamine on KP-001 PK in Volunteers
Start: Feb 13, 2025
Completion: May 20, 2025
Loading map...